[Back to Issue 05 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]
[View Full Article] [Download Reprint (PDF)]

REVIEW: Integrating Dopamine and BDNF Hypotheses: The Role of Dopamine–BDNF Crosstalk in Neuropathologies


Marah Alsalloum1,2,a, Anton Tsybko1,2,b* and Vladimir Naumenko1,c

1Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia

2Novosibirsk State University, 630090 Novosibirsk, Russia

* To whom correspondence should be addressed.

Received: November 28, 2025; Revised: February 17, 2026; Accepted: February 18, 2026
The dopamine system plays an important role in numerous physiological processes, such as locomotion, emotions, reward behavior, memory, and learning. Differentiation and proper functioning of dopaminergic neurons are largely promoted by the brain-derived neurotrophic factor (BDNF). BDNF is one of the most abundant neurotrophins in the mammalian brain and is implicated in neuronal development, differentiation, and plasticity. Dysfunction of dopaminergic system and BDNF signaling are linked to the pathogenesis of many neurological disorders, including Parkinson’s disease, schizophrenia, autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and others. Accumulating evidence indicates a significant crosstalk between BDNF and dopamine system, the disruption of which might underlie the development of various neuro- and psychopathologies. In this review, we summarized recent data on the interplay between BDNF and brain dopamine system under physiological conditions, as well as in neurodevelopmental and neurodegenerative disorders. The available data suggest that the crosstalk between the brain dopamine system and BDNF is essential for normal neurophysiology; it is also involved in neuropathology and could serve as a target for therapeutic strategies aimed at correcting pathological behaviors.
KEY WORDS: brain-derived neurotrophic factor, Bdnf, dopamine, neurodevelopmental disorders, neurodegenerative disorders

DOI: 10.1134/S0006297925604125

Publisher’s Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.